Efficacy of different indocyanine green doses in fluorescent laparoscopic cholecystectomy: A prospective, randomized, double‐blind trial
Journal of Surgical Oncology · 2024
DOI: 10.1002/jso.27684 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Surgical Oncology, 2024. Verfasst von Siyu Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, the First Affiliated Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Indocyanine Green, Cholecystectomy, Laparoscopic. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, The University Research Project of Anhui Province.
Abstract (Originalsprache)
Background and Objectives Intraoperative bile duct injury is a significant complication in laparoscopic cholecystectomy (LC). Near‐infrared fluorescence cholangiography (NIFC) can reduce this complication. Therefore, determining the optimal indocyanine green (ICG) dosage for effective NIFC is crucial. This study aimed to determine the optimal ICG dosage for NIFC.
Methods
This was a prospective, randomized, double‐blind clinical trial at a single tertiary referral center, including 195 patients randomly assigned to three groups: lower dose (0.01 mg/BMI) ICG ( n = 63), medium dose (0.02 mg/BMI) ICG ( n = 68), and higher dose (0.04 mg/BMI) ICG ( n = 64). Surgeon satisfaction and detection rates for seven biliary structures were compared among the three dose groups.
Results
Demographic parameters did not significantly differ among the groups. The medium dose (72.1%) and higher dose ICG groups (70.3%) exhibited superior visualization of the common hepatic duct compared to the lower dose group (41.3%) ( p < 0.001). No differences existed between the medium and higher dose groups. Similar trends were observed for the common bile duct and cystic common bile duct junction.
Conclusions
In patients undergoing fluorescent laparoscopic cholecystectomy, the 0.02 mg/BMI dose of indocyanine green demonstrated better biliary structure detection rates than the 0.01 mg/BMI dose and was non‐inferior to the 0.04 mg/BMI dose.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
Förderung
- National Natural Science Foundation of China
- The University Research Project of Anhui Province
Zitieren
APA
Wang, S., Yuan, W., Yu, A., Gu, W., Wang, T., Zhang, C., & Zhang, C. (2024). Efficacy of different indocyanine green doses in fluorescent laparoscopic cholecystectomy: A prospective, randomized, double‐blind trial. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27684
Vancouver
Wang S, Yuan W, Yu A, Gu W, Wang T, Zhang C, et al. Efficacy of different indocyanine green doses in fluorescent laparoscopic cholecystectomy: A prospective, randomized, double‐blind trial. Journal of Surgical Oncology. 2024. doi:10.1002/jso.27684
BibTeX
@article{Wang2024,
author = {Wang, Siyu and Yuan, Wenkang and Yu, Anhai and Gu, Wang and Wang, Tianqi and Zhang, Chong and Zhang, Chao},
title = {Efficacy of different indocyanine green doses in fluorescent laparoscopic cholecystectomy: A prospective, randomized, double‐blind trial},
journal = {Journal of Surgical Oncology},
year = {2024},
doi = {10.1002/jso.27684}
}
EUVIMED